Literature DB >> 30027513

Comment on "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials".

Joseph F Standing1, Brian J Anderson2, Stefanie Hennig3, Nick H Holford4, Trevor N Johnston5, Catherijne A J Knibbe6, Dagan O Lonsdale7, Amin Rostami-Hodjegan8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30027513     DOI： 10.1007/s40262-018-0697-7

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  11 in total

1.  A bodyweight-dependent allometric exponent for scaling clearance across the human life-span.

Authors:  Chenguang Wang; Mariska Y M Peeters; Karel Allegaert; Heleen J Blussé van Oud-Alblas; Elke H J Krekels; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

2.  Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology.

Authors:  Akshanth R Polepally; Rory P Remmel; Richard C Brundage; Ilo E Leppik; John O Rarick; R Eugene Ramsay; Angela K Birnbaum
Journal:  J Clin Pharmacol       Date:  2015-08-18       Impact factor: 3.126

Review 3.  A pharmacokinetic standard for babies and adults.

Authors:  Nick Holford; Young-A Heo; Brian Anderson
Journal:  J Pharm Sci       Date:  2013-05-06       Impact factor: 3.534

4.  Prediction of morphine dose in humans.

Authors:  Nick H G Holford; Shu C Ma; Brian J Anderson
Journal:  Paediatr Anaesth       Date:  2011-12-28       Impact factor: 2.556

5.  Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials.

Authors:  Sven C van Dijkman; Nico C B de Jager; Willem M Rauwé; Meindert Danhof; Oscar Della Pasqua
Journal:  Clin Pharmacokinet       Date:  2018-08       Impact factor: 6.447

6.  Correction to: Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials.

Authors:  Sven C van Dijkman; Nico C B de Jager; Willem M Rauwé; Meindert Danhof; Oscar Della Pasqua
Journal:  Clin Pharmacokinet       Date:  2018-08       Impact factor: 6.447

7.  Predicting weight using postmenstrual age--neonates to adults.

Authors:  Anita L Sumpter; Nick H G Holford
Journal:  Paediatr Anaesth       Date:  2011-03       Impact factor: 2.556

8.  Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.

Authors:  Jeannine S McCune; Meagan J Bemer; Jeffrey S Barrett; K Scott Baker; Alan S Gamis; Nicholas H G Holford
Journal:  Clin Cancer Res       Date:  2013-11-11       Impact factor: 12.531

9.  Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis.

Authors:  Stefanie Hennig; Joseph F Standing; Christine E Staatz; Alison H Thomson
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

10.  Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?

Authors:  Elisa A M Calvier; Elke H J Krekels; Pyry A J Välitalo; Amin Rostami-Hodjegan; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447
View more
  1 in total

1.  Authors' Reply to Standing et al.: "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials".

Authors:  Sven C van Dijkman; Nico C B de Jager; Willem M Rauwé; Meindert Danhof; Oscar Della Pasqua
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.